MedPath

Treatment efficacy of short-term PEG-IFN alpha for chronic hepatitis C patients with genotype 2 and low viral road

Phase 4
Conditions
chronic hepatitis C
Registration Number
JPRN-UMIN000001170
Lead Sponsor
Gunma Liver Study Group
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
220
Inclusion Criteria

Not provided

Exclusion Criteria

liver dysfunction with other causes Allergy to Interferon (IFN) during pregnancy Severe comlication-especially, poor hematopoiesis, renal, cardiac or respiratory function

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
HCV-RNA
Secondary Outcome Measures
NameTimeMethod
transaminase
© Copyright 2025. All Rights Reserved by MedPath